Literature DB >> 32207404

Pregnancy and Chagas Disease: Benznidazole's Impact on Pregnancy and Newborns: A Report of Four Cases.

Cristina Vázquez1, Elisa García-Vázquez2,1, Bartolomé Carrilero1, Marina Simón1, Fuensanta Franco1, Maria A Iborra2,1, Luis J Gil-Gallardo1, Manuel Segovia2,1.   

Abstract

In recent decades and because of migration, Chagas disease has become a global public health problem. A significant focus has been placed on pregnant women who can transmit the disease to their offspring. Here, we report four cases of women who did not know that they were pregnant while they were being treated with benznidazole. A diagnosis was established according to serology and Trypanosoma cruzi polymerase chain reaction (PCR)-standardized tests. Treatment was discontinued when pregnancy was confirmed, and a thorough follow-up was carried out. Although each case was different, none of the mothers developed health problems during pregnancy, and their newborns were delivered without any teratogenic effects.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32207404      PMCID: PMC7204601          DOI: 10.4269/ajtmh.19-0348

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  25 in total

1.  Oral tinidazole treatment during pregnancy and teratogenesis.

Authors:  A E Czeizel; Z Kazy; P Vargha
Journal:  Int J Gynaecol Obstet       Date:  2003-12       Impact factor: 3.561

2.  [Comparative controlled study on the use of benznidazole, nifurtimox and placebo, in the chronic form of Chagas' disease, in a field area with interrupted transmission. I. Preliminary evaluation].

Authors:  J R Coura; L L de Abreu; H P Willcox; W Petana
Journal:  Rev Soc Bras Med Trop       Date:  1997 Mar-Apr       Impact factor: 1.581

3.  2 nd Brazilian Consensus on Chagas Disease, 2015.

Authors:  João Carlos Pinto Dias; Alberto Novaes Ramos; Eliane Dias Gontijo; Alejandro Luquetti; Maria Aparecida Shikanai-Yasuda; José Rodrigues Coura; Rosália Morais Torres; José Renan da Cunha Melo; Eros Antonio de Almeida; Wilson de Oliveira; Antônio Carlos Silveira; Joffre Marcondes de Rezende; Fabiane Scalabrini Pinto; Antonio Walter Ferreira; Anis Rassi; Abílio Augusto Fragata; Andréa Silvestre de Sousa; Dalmo Correia; Ana Maria Jansen; Glaucia Manzan Queiroz Andrade; Constança Felícia De Paoli de Carvalho Britto; Ana Yecê das Neves Pinto; Anis Rassi; Dayse Elisabeth Campos; Fernando Abad-Franch; Silvana Eloi Santos; Egler Chiari; Alejandro Marcel Hasslocher-Moreno; Eliane Furtado Moreira; Divina Seila de Oliveira Marques; Eliane Lages Silva; José Antonio Marin-Neto; Lúcia Maria da Cunha Galvão; Sergio Salles Xavier; Sebastião Aldo da Silva Valente; Noêmia Barbosa Carvalho; Alessandra Viana Cardoso; Rafaella Albuquerque E Silva; Veruska Maia da Costa; Simone Monzani Vivaldini; Suelene Mamede Oliveira; Vera da Costa Valente; Mayara Maia Lima; Renato Vieira Alves
Journal:  Rev Soc Bras Med Trop       Date:  2016-12       Impact factor: 1.581

4.  [Chagas disease and pregnancy. Review apropos of a clinical case. Treatment].

Authors:  R Almuna; E Salgado; H Reyes; B Gottlieb; M Capetillo
Journal:  Rev Chil Obstet Ginecol       Date:  1981

5.  What to expect and when: benznidazole toxicity in chronic Chagas' disease treatment.

Authors:  E Aldasoro; E Posada; A Requena-Méndez; A Calvo-Cano; N Serret; A Casellas; S Sanz; D Soy; M J Pinazo; J Gascon
Journal:  J Antimicrob Chemother       Date:  2018-04-01       Impact factor: 5.790

6.  Treatment of Infected Women of Childbearing Age Prevents Congenital Trypanosoma cruzi Infection by Eliminating the Parasitemia Detected by PCR.

Authors:  Laura Murcia; Marina Simón; Bartolomé Carrilero; Mercedes Roig; Manuel Segovia
Journal:  J Infect Dis       Date:  2017-05-01       Impact factor: 5.226

Review 7.  Control and management of congenital Chagas disease in Europe and other non-endemic countries: current policies and practices.

Authors:  Antoni Soriano-Arandes; Andrea Angheben; Nuria Serre-Delcor; Begoña Treviño-Maruri; Jordi Gómez I Prat; Yves Jackson
Journal:  Trop Med Int Health       Date:  2016-03-17       Impact factor: 2.622

8.  Limited infant exposure to benznidazole through breast milk during maternal treatment for Chagas disease.

Authors:  Facundo García-Bournissen; Samanta Moroni; Maria Elena Marson; Guillermo Moscatelli; Guido Mastrantonio; Margarita Bisio; Laura Cornou; Griselda Ballering; Jaime Altcheh
Journal:  Arch Dis Child       Date:  2014-09-10       Impact factor: 3.791

Review 9.  Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities.

Authors:  Rodolfo Viotti; Carlos Vigliano; Bruno Lococo; Maria Gabriela Alvarez; Marcos Petti; Graciela Bertocchi; Alejandro Armenti
Journal:  Expert Rev Anti Infect Ther       Date:  2009-03       Impact factor: 5.091

10.  Access to benznidazole for Chagas disease in the United States-Cautious optimism?

Authors:  Jonathan D Alpern; Rogelio Lopez-Velez; William M Stauffer
Journal:  PLoS Negl Trop Dis       Date:  2017-09-14
View more
  1 in total

Review 1.  Screening for Chagas Disease during Pregnancy in the United States-A Literature Review.

Authors:  Elizabeth G Livingston; Ryan Duggal; Sarah Dotters-Katz
Journal:  Trop Med Infect Dis       Date:  2021-11-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.